Abortion Pill Reversal Information Act

Abortion Pill Reversal Information Act

SB 155

Take Action


Introduced in the Ohio Senate - May 28, 2019

Passed out the Senate Health, Human Services, and Medicaid Committee- November 5, 2019 

Passed the Ohio Senate- November 6, 2019 

Introduced in the Ohio House- November 12, 2019 

The proposed legislation requires doctors prescribing a Mifepristone chemical abortion to also provide written information informing the patient of scientifically proven abortion reversal procedures in the event she changes her mind.  

The Mifeprex chemical abortion procedure is a two-day regimen used to terminate early pregnancies by blocking the hormone progesterone needed to sustain pregnancy with the first drug, Mifepristone. A second drug, Misoprostol, stimulates uterine contraction to expel the dead baby.  Women who choose chemical abortion and regret it within the first two days of taking the first drug have a chance to save their baby, as long as they have not taken the second drug.  The reversal procedure has been proven to be successful in 64-68% of cases. The procedure involves administering progesterone to the mother, which can reverse the impact of the first drug and allow the baby to continue normal development.

Bill Sponsors

Peggy Lehner

Ohio State Senator (R)
(614) 466-4538

Ohio Right To Life
88 East Broad Street, Suite 620
Columbus, OH 43215

[email protected]
(614) 547-0099
Copyright 2018